On the upside
NII Holdings (Nasdaq: NIHD) chief executive Steve Dussek increased his stake in the company by 12%.
A Seeking Alpha contributor expects ACADIA Pharmaceuticals' (Nasdaq: ACAD) pimavanserin to be the first antipsychotic to be approved to treat Parkinson's Disease Psychosis.
On the downside
Skyworks Solutions (Nasdaq: SWKS) lifted its fourth quarter earnings outlook but the stock price fell.
J.C. Penney (NYSE: JCP) chief executive Ron Johnson warned that challenges would continue for the retailer.
Norfolk Southern (NYSE: NSC) warned that third quarter results would drop.
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on both the NYSE and on Nasdaq. The Russell 2000 which tracks small cap stocks lost 4 points to 851.